Literature DB >> 3496796

In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters.

T An, U Sood, T Pietruk, G Cummings, K Hashimoto, J D Crissman.   

Abstract

The authors examined inflammatory mononuclear cells in 10 fibroadenomas and 56 ductal infiltrating type carcinomas of the breast to see whether the distribution of various subpopulations of the mononuclear cells were correlated with known histologic, biochemical, and clinical parameters of the cancers. T cells, B cells, natural killer cells, and macrophages were quantitated on frozen tissue sections, which were stained with monoclonal antibodies, as demonstrated by the immunoperoxidase technique. The carcinomas had significantly higher numbers of T cells, Leu-3+ helper-inducer cells, T8+ cytotoxic-suppressor cells, M5+ macrophages, and T6+ Langerhans cells than the fibroadenomas. There were no significant differences in the distribution of natural killer cells. Among these mononuclear subsets, helper-inducer T cells were the primary cell type in both benign and malignant neoplasms. Estrogen receptor-positive carcinoma had significantly fewer numbers of T cells and the subgroup of Leu-3+ helper-inducer cells. Clinical Stage 3 cancers had significantly fewer numbers of T cells and natural killer cells than both fibroadenomas and Stage I and II neoplasms. Prominent infiltration of T cells, specifically helper-inducer cells, is not associated with estrogen receptor positivity, which is known to be a favorable prognostic marker of breast carcinoma. The findings of fewer T cells and natural killer cells in Stage 3 carcinomas are intriguing but unexplained.

Entities:  

Mesh:

Year:  1987        PMID: 3496796      PMCID: PMC1899793     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques.

Authors:  R Schoorl; A B Riviere; A E Borne; T M Feltkamp-Vroom
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

2.  The Langerhans cell.

Authors:  K Wolff; G Stingl
Journal:  J Invest Dermatol       Date:  1983-06       Impact factor: 8.551

3.  Characterization of Langerhans cells by the use of monoclonal antibodies.

Authors:  G F Murphy; A K Bhan; S Sato; T J Harrist; M C Mihm
Journal:  Lab Invest       Date:  1981-11       Impact factor: 5.662

4.  Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer.

Authors:  D F Roses; D A Bell; T J Flotte; R Taylor; H Ratech; N Dubin
Journal:  Am J Clin Pathol       Date:  1982-12       Impact factor: 2.493

5.  Correlation of hormone receptors with pathological features in human breast cancer.

Authors:  R R Millis
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

6.  Immunocompetence, immunosuppression, and human breast cancer. II. Further evidence of initial immune impairment by integrated assessment effect of nodal involvement (N) and of primary tumor size (T).

Authors:  A Adler; J A Stein; S Ben-Efraim
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

7.  Carcinoma of the breast: interrelationships among histopathologic features, estrogen receptor activity, and age of the patient.

Authors:  A B Chabon; J D Goldberg; L Venet
Journal:  Hum Pathol       Date:  1983-04       Impact factor: 3.466

8.  Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T- and B-cell sera.

Authors:  I Shimokawara; M Imamura; N Yamanaka; Y Ishii; K Kikuchi
Journal:  Cancer       Date:  1982-04-01       Impact factor: 6.860

9.  Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women.

Authors:  S Cunningham-Rundles; D A Filippa; D W Braun; P Antonelli; H Ashikari
Journal:  J Natl Cancer Inst       Date:  1981-09       Impact factor: 13.506

10.  Langerhans cells and serum precipitating antibodies against fungal antigens in bronchioloalveolar cell carcinoma: possible association with pulmonary eosinophilic granuloma.

Authors:  S P Hammar; D Bockus; F Remington; K O Hallman; R H Winterbauer; L D Hill; D E Bauermeister; H W Jones; R P Mennemeyer; R F Wheelis
Journal:  Ultrastruct Pathol       Date:  1980 Jan-Mar       Impact factor: 1.094

View more
  21 in total

1.  The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

Authors:  R Salgado; C Denkert; S Demaria; N Sirtaine; F Klauschen; G Pruneri; S Wienert; G Van den Eynden; F L Baehner; F Penault-Llorca; E A Perez; E A Thompson; W F Symmans; A L Richardson; J Brock; C Criscitiello; H Bailey; M Ignatiadis; G Floris; J Sparano; Z Kos; T Nielsen; D L Rimm; K H Allison; J S Reis-Filho; S Loibl; C Sotiriou; G Viale; S Badve; S Adams; K Willard-Gallo; S Loi
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

2.  Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer.

Authors:  R Bilik; C Mor; B Hazaz; C Moroz
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma.

Authors:  Georgi Atanasov; Corinna Dietel; Linda Feldbrügge; Christian Benzing; Felix Krenzien; Andreas Brandl; Elli Mann; Julianna Paulina Englisch; Katrin Schierle; Simon C Robson; Katrin Splith; Mehmet Haluk Morgul; Anja Reutzel-Selke; Sven Jonas; Andreas Pascher; Marcus Bahra; Johann Pratschke; Moritz Schmelzle
Journal:  Oncoimmunology       Date:  2017-06-28       Impact factor: 8.110

4.  Distribution and clinical significance of tumour-associated macrophages in pancreatic ductal adenocarcinoma: a retrospective analysis in China.

Authors:  S J Chen; Q B Zhang; L J Zeng; G D Lian; J J Li; C C Qian; Y Z Chen; Y T Chen; K H Huang
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

5.  Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer.

Authors:  Derrick Wansom; Emily Light; Dafydd Thomas; Francis Worden; Mark Prince; Susan Urba; Douglas Chepeha; Bhavna Kumar; Kitrina Cordell; Avraham Eisbruch; Jeremy Taylor; Jeffrey Moyer; Carol Bradford; Nisha D'Silva; Thomas Carey; Jonathan McHugh; Gregory Wolf
Journal:  Laryngoscope       Date:  2012-01       Impact factor: 3.325

6.  Near eradication of clinically relevant concentrations of human tumor cells by interferon-activated monocytes in vitro.

Authors:  Samuel Baron; Joel Finbloom; Julie Horowitz; Joseph Bekisz; Angel Morrow; Tongmao Zhao; Samuel Fey; Hana Schmeisser; Corey Balinsky; Kotaro Miyake; Christopher Clark; Kathryn Zoon
Journal:  J Interferon Cytokine Res       Date:  2011-02-16       Impact factor: 2.607

7.  Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome.

Authors:  A Bellocq; M Antoine; A Flahault; C Philippe; B Crestani; J F Bernaudin; C Mayaud; B Milleron; L Baud; J Cadranel
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

8.  The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer.

Authors:  Hai Hu; Jun-Jie Hang; Ting Han; Meng Zhuo; Feng Jiao; Li-Wei Wang
Journal:  Tumour Biol       Date:  2016-01-06

9.  Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival.

Authors:  H O Wintzer; W Bohle; S von Kleist
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 10.  Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.

Authors:  R Clarke
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.